Skip to content

New Therapies for bone and cartilage defects using bone marrow

New Therapies for bone and cartilage defects using bone marrow - Bone Marrow

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON43408
Enrollment
200
Registered
2016-03-15
Start date
2016-08-29
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

not applicable

Interventions

None listed

Sponsors

Orthopaedie
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: undergoing total hip replacement surgery

Exclusion criteria

Exclusion criteria: had radiation therapy in the hip area haematologic disorders (such as leukemia or hemophilia)

Design outcomes

Primary

MeasureTime frame
First the cells of interest will be isolated from the bone marrow biopsy and then subjected to a series of culture and analyses methods. The exact methods will depend on the research question. We will characterize the cells using FACS analyses and evaluate the capacity to form bone or cartilage using histology, mRNA and protein analyses. Furthermore the capacity of the cells to inhibit inflammation will be evaluated in the laboratory by bringing them in contact with immune cells. All research is aimed to find methods to improve the treatment of cartilage and bone defects.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)